Rachel N. Grisham

Also affiliated with Cornell University, Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 44 papers. Top paper: “MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum”.

MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

Journal of Clinical Oncology(2020)10.1200/jco.20.01164

N/A

4.6DataRank · unranked

153 citations

Rachel N. Grisham, Susana Banerjee, Elsa Kalbacher, Mansoor Raza Mirza, Ignacio Romero +25 more

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0621

N/A

0.949DataRank · unranked

22 citations

Ignace Vergote, Susana Banerjee, Esther Drill, Elsa Kalbacher, Mansoor Raza Mirza +25 more

Ovarian cancer mutational processes drive site-specific immune evasion

Nature(2022)10.1038/s41586-022-05496-1

N/A

0.863DataRank · unranked

314 citations

Florian Uhlitz, Nicholas Ceglia, Jamie Lim, Michelle Wu, Neeman Mohibullah +56 more

Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.023

N/A

0.835DataRank · unranked

20 citations

Erin McMinn, Effi Yeoshoua, Thomas Boerner, Qin Zhou, Alexia Iasonos +13 more

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005919

N/A

0.812DataRank · unranked

25 citations

Bradley J. Monk, Els Van Nieuwenhuysen, Kathleen N. Moore, Michel Fabbro, David M. O’Malley +16 more

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Journal of Clinical Oncology(2025)10.1200/jco-25-00112

N/A

0.722DataRank · unranked

36 citations

Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D’Hondt, Bradley J. Monk, Andrew R. Clamp +20 more

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028

N/A

0.583DataRank · unranked

12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

Nature(2025)10.1038/s41586-025-09240-3

N/A

0.553DataRank · unranked

39 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Duaa H. Al-Rawi, Matthew Zatzman, Adam C. Weiner +53 more

Controversies in the Management of Mesonephric and Mesonephric-Like Adenocarcinomas of the Female Genital Tract

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101638

N/A

0.276DataRank · unranked

4 citations

Kay J. Park, Simran Makker, Jeffrey Girshman, Carol Aghajanian, Rachel N. Grisham +1 more

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Scientific Reports(2022)10.1038/s41598-021-04618-5

N/A

0DataRank · unranked

33 citations

Beryl Manning‐Geist, Christina Henson, Gopa Iyer, Ginger J. Gardner, Yukio Sonoda +5 more

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Cancer(2023)10.1002/cncr.34753

N/A

0DataRank · unranked

19 citations

Ryan Kahn, David Nemirovsky, Jeffrey Girshman, Anya Laibangyang, Sushmita Gordhandas +8 more

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.11.019

N/A

0DataRank · unranked

19 citations

Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Sia +23 more

The highs and lows of serous ovarian cancer

Cancer(2023)10.1002/cncr.34903

N/A

0DataRank · unranked

15 citations

Beryl Manning‐Geist, M. Herman Chui, Rachel N. Grisham

Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.022

N/A

0DataRank · unranked

11 citations

Beryl Manning‐Geist, Andrea Knežević, Luxue Deng, Maria Bromberg, Samuel A. Funt +13 more

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.003

N/A

0DataRank · unranked

10 citations

Qin Zhou, Alexia Iasonos, Lea A. Moukarzel, Kimberly Dessources, Krysten Soldan +11 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024

N/A

0DataRank · unranked

8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-004576

N/A

0DataRank · unranked

1 citations

Clarissa Lam, Derman Başaran, Ying L. Liu, Rachel N. Grisham, William P. Tew +9 more

Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.07.006

N/A

0DataRank · unranked

3 citations

Beryl Manning‐Geist, Sarah Ehmann, Jessica A. Lavery, Carrie Luardo, Aaron Praiss +10 more

Beyond the estrogen receptor: In search of predictive biomarkers for low‐grade serous ovarian cancer

Cancer(2023)10.1002/cncr.34658

N/A

0DataRank · unranked

2 citations

Beryl Manning‐Geist, M. Herman Chui, Rachel N. Grisham

Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets

Advances in Oncology(2023)10.1016/j.yao.2023.01.004

N/A

0DataRank · unranked

1 citations

Aaron Praiss, Chrisann Kyi, Kay J. Park, Rachel N. Grisham

Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5565

N/A

0DataRank · unranked

0 citations

Pier Selenica, Thomas Boerner, Yonghong Xiao, Tiffany Sia, Margaret Sheehan +15 more

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.10.087

N/A

0DataRank · unranked

12 citations

Sushmita Gordhandas, Dilip D. Giri, Alexia Iasonos, Qin Zhou, Jeffrey Girshman +12 more

Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.07.030

N/A

0DataRank · unranked

32 citations

Thomas Boerner, Jessa Suhner, Dib Sassine, Ying Liu, Rachel N. Grisham +10 more

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.008

N/A

0DataRank · unranked

20 citations

Mackenzie W. Sullivan, Qin Zhou, Alexia Iasonos, Pier Selenica, Chrystal Stallworth +9 more

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1999

N/A

0DataRank · unranked

16 citations

Qin Zhou, Alexia Iasonos, William A. Zammarrelli, Britta Weigelt, Lora H. Ellenson +17 more

Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.015

N/A

0DataRank · unranked

17 citations

Charlie White, Alexia Iasonos, Pier Selenica, Oliver Zivanovic, S. Dennis +7 more

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019

N/A

0DataRank · unranked

16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Cancer(2024)10.1002/cncr.35523

N/A

0DataRank · unranked

8 citations

Stephen Graves, Anusha Adkoli, Qin Zhou, Alexia Iasonos, Lora H. Ellenson +8 more

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.026

N/A

0DataRank · unranked

5 citations

Lindsey Finch, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +14 more

Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.006

N/A

0DataRank · unranked

4 citations

Clarissa Lam, Qin Zhou, Alexia Iasonos, Rachel N. Grisham, William P. Tew +7 more

Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.11.011

N/A

0DataRank · unranked

3 citations

Mackenzie W. Sullivan, Anusha Adkoli, Qin Zhou, Alexia Iasonos, Pier Selenica +10 more

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.11.602772

N/A

0DataRank · unranked

11 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Matthew Zatzman, Duaa H. Al-Rawi, Adam C. Weiner +52 more

A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005660

N/A

0DataRank · unranked

0 citations

Thomas Boerner, Michael Kim, Clarissa Lam, Sushmita Gordhandas, Effi Yeoshoua +11 more

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline

Journal of Clinical Oncology(2020)10.1200/jco.19.02960

N/A

0DataRank · unranked

383 citations

Barbara M. Norquist, Christina Lacchetti, Deborah K. Armstrong, Rachel N. Grisham, Paul J. Goodfellow +7 more

Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3168

N/A

0DataRank · unranked

6 citations

Eun-Young Kang, Ryan Kahn, Sarah Chiang, Qin Zhou, Alexia Iasonos +7 more

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2024.100005

N/A

0DataRank · unranked

3 citations

Sarah Andres, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +15 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.583

N/A

0DataRank · unranked

5 citations

Anne M. Mills, Brooke E. Howitt, Rachel N. Grisham, Elizabeth D. Euscher, Hyun Soo Kim +16 more

Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101938

N/A

0DataRank · unranked

3 citations

Rachel N. Grisham, Robert L. Coleman, Lauren Cobb, Bradley J. Monk, Thomas J. Herzog +3 more

Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.021

N/A

0DataRank · unranked

2 citations

M. Herman Chui, Pier Selenica, Kara Long Roche, Yukio Sonoda, Rachel N. Grisham +6 more

Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-003935

N/A

0DataRank · unranked

10 citations

Sushmita Gordhandas, Anjelica Hodgson, Qin Zhou, Alexia Iasonos, S. Dennis +12 more

Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets

Hematology/Oncology Clinics of North America(2025)10.1016/j.hoc.2025.04.015

N/A

0DataRank · unranked

0 citations

Aaron Praiss, Chrisann Kyi, Kay J. Park, Rachel N. Grisham

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.030

N/A

0DataRank · unranked

11 citations

Olga T. Filippova, Sushmita Gordhandas, Anjile An, Alli Straubhar, Oliver Zivanovic +9 more